Adeno-associated virus vectors integrate at chromosome breakage sites
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Adeno-associated virus (AAV) vectors transduce cells by multiple pathways, including integration at nonhomologous chromosomal locations by an unknown mechanism. We reasoned that spontaneous chromosome breaks may facilitate vector integration and investigated this in cells containing a specific chromosomal double-strand break created by the endonuclease I-SceI or multiple breaks created by treatment with etoposide or gamma-irradiation. Vector proviruses were found at I-SceI cleavage sites, and sequencing of vector-chromosome junctions detected microhomologies, deletions and insertions that were similar when integration occurred spontaneously at random locations or at induced double-strand breaks. Infection with AAV vectors did not increase mutation rates in normal human cells. Our results establish a mechanism for integration and suggest that AAV vectors can integrate at existing chromosome breaks rather than causing breaks themselves, which has implications for their clinical use.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Integration events can be increased by increasing dsDNA breaks in vitro by adding intron-encoded endonuclease I-SceI, etoposide, or γ-irradiation [244].”
From Recombinant Adeno-Associated Viral Vectors (rAAV)-Vector Elements in Ocular Gene Therapy Clinical Trials and Transgene Expression and Bioactivity Assays (2020) · cites this paper as [244]
Citations
Cites
Evidence for a lack of DNA double-strand break repair in human cells exposed to very low x-ray doses
Rothkamm, K., & Löbrich, M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0830918100 · Cited by 1,645
Zolotukhin, S., Byrne, B. J., Mason, E., Zolotukhin, I., Potter, M., Chesnut, K., Summerford, C., Samulski, R. J., & Muzyczka, N. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300938 · Cited by 1,312
Rouet, P., Smih, F., & Jasin, M. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.12.8096 · Cited by 791
Novel Tools for Production and Purification of Recombinant Adenoassociated Virus Vectors
Grimm, D., Kern, A., Rittner, K., & Kleinschmidt, J. A. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.18-2745 · Cited by 696
Homology-directed repair is a major double-strand break repair pathway in mammalian cells
Liang, F., Han, M., Romanienko, P. J., & Jasin, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.9.5172 · Cited by 649 · cited 1×
“, as these can also occur when DSBs undergo normal cellular repair processe”
BackgroundQuantitative Detection of125IdU-Induced DNA Double-Strand Breaks with γ-H2AX Antibody
Sedelnikova, O. A., Rogakou, E. P., Panyutin, I. G., & Bonner, W. M. (2002) · Radiation Research · doi:10.1667/0033-7587(2002)158[0486:qdoiid]2.0.co;2 · Cited by 611 · cited 1×
“These low values are consistent with the expected toxicity of DSBs and with earlier estimates based on staining for γ-H2A”
ResultFrequent chromosomal translocations induced by DNA double-strand breaks
Richardson, C., & Jasin, M. (2000) · Nature · doi:10.1038/35015097 · Cited by 517 · cited 1×
“, as these can also occur when DSBs undergo normal cellular repair processe”
BackgroundMechanism of action of eukaryotic topoisomerase II and drugs targeted to the enzyme
Burden, D. A., & Osheroff, N. (1998) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(98)00132-8 · Cited by 503
Yee, J. K., Miyanohara, A., LaPorte, P., Bouic, K., Burns, J. C., & Friedmann, T. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.20.9564 · Cited by 487
Single-strand interruptions in replicating chromosomes cause double-strand breaks
Kuzminov, A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.131009198 · Cited by 406
Cited by
CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells
Dever, D. P., Bak, R. O., Reinisch, A., Camarena, J., Washington, G., Nicolas, C. E., Pavel-Dinu, M., Saxena, N., Wilkens, A. B., Mantri, S., et al. (2016) · Nature · doi:10.1038/nature20134 · Cited by 864
GENE THERAPY: Twenty-First Century Medicine
Verma, I. M., & Weitzman, M. D. (2005) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.74.050304.091637 · Cited by 616
Towards safe, non-viral therapeutic gene expression in humans
Glover, D. J., Lipps, H. J., & Jans, D. A. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1577 · Cited by 598
High, K. A., & Roncarolo, M. G. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1706910 · Cited by 555
In vivo genome editing restores haemostasis in a mouse model of haemophilia
Li, H., Haurigot, V., Doyon, Y., Li, T., Wong, S. Y., Bhagwat, A. S., Malani, N., Anguela, X. M., Sharma, R., Ivanciu, L., et al. (2011) · Nature · doi:10.1038/nature10177 · Cited by 548
CRISPR-Based Therapeutic Genome Editing: Strategies and In Vivo Delivery by AAV Vectors
Wang, D., Zhang, F., & Gao, G. (2020) · Cell · doi:10.1016/j.cell.2020.03.023 · Cited by 527
An unbiased genome-wide analysis of zinc-finger nuclease specificity
Gabriel, R., Lombardo, A., Arens, A., Miller, J. C., Genovese, P., Kaeppel, C., Nowrouzi, A., Bartholomae, C. C., Wang, J., Friedman, G., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1948 · Cited by 526
Self-complementary AAV vectors; advances and applications
McCarty, D. M. (2008) · Molecular Therapy · doi:10.1038/mt.2008.171 · Cited by 515
Shun, M.-C., Raghavendra, N. K., Vandegraaff, N., Daigle, J. E., Hughes, S., Kellam, P., Cherepanov, P., & Engelman, A. (2007) · Genes & Development · doi:10.1101/gad.1565107 · Cited by 467
“Rep-deficient AAV vectors, which integrate via cellular DNA double-strand breaks (Miller et al. 2004), can be considered a benchmark for random mobile DNA insertion in the human genome.”
BackgroundIntegration of Adeno-Associated Virus (AAV) and Recombinant AAV Vectors
McCarty, D. M., Young, S. M., & Samulski, R. J. (2004) · Annual Review of Genetics · doi:10.1146/annurev.genet.37.110801.143717 · Cited by 450
Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy
Nelson, C. E., Wu, Y., Gemberling, M. P., Oliver, M. L., Waller, M. A., Bohning, J. D., Robinson-Hamm, J. N., Bulaklak, K., Castellanos Rivera, R. M., Collier, J. H., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0344-3 · Cited by 430
High levels of AAV vector integration into CRISPR-induced DNA breaks
Hanlon, K. S., Kleinstiver, B. P., Garcia, S. P., Zaborowski, M. P., Volak, A., Spirig, S. E., Muller, A., Sousa, A. A., Tsai, S. Q., Bengtsson, N. E., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12449-2 · Cited by 431
Zinc-finger Nucleases: The Next Generation Emerges
Cathomen, T., & Keith Joung, J. (2008) · Molecular Therapy · doi:10.1038/mt.2008.114 · Cited by 353
Viral gene therapy strategies: from basic science to clinical application
Young, L. S., Searle, P. F., Onion, D., & Mautner, V. (2006) · The Journal of Pathology · doi:10.1002/path.1896 · Cited by 313
The delivery challenge: fulfilling the promise of therapeutic genome editing
van Haasteren, J., Li, J., Scheideler, O. J., Murthy, N., & Schaffer, D. V. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0565-5 · Cited by 285
Adeno-associated virus: from defective virus to effective vector
Gonçalves, M. A. (2005) · Virology Journal · doi:10.1186/1743-422x-2-43 · Cited by 264
Wang, J., Exline, C. M., DeClercq, J. J., Llewellyn, G. N., Hayward, S. B., Li, P. W.-L., Shivak, D. A., Surosky, R. T., Gregory, P. D., Holmes, M. C., et al. (2015) · Nature Biotechnology · doi:10.1038/nbt.3408 · Cited by 261
HLA engineering of human pluripotent stem cells
Riolobos, L., Hirata, R. K., Turtle, C. J., Wang, P.-R., Gornalusse, G. G., Zavajlevski, M., Riddell, S. R., & Russell, D. W. (2013) · Molecular Therapy · doi:10.1038/mt.2013.59 · Cited by 253
Self-citationAssessing the potential for AAV vector genotoxicity in a murine model
Li, H., Malani, N., Hamilton, S. R., Schlachterman, A., Bussadori, G., Edmonson, S. E., Shah, R., Arruda, V. R., Mingozzi, F., Fraser Wright, J., et al. (2011) · Blood · doi:10.1182/blood-2010-08-302729 · Cited by 236
Characterization of Adeno-Associated Virus Genomes Isolated from Human Tissues
Schnepp, B. C., Jensen, R. L., Chen, C.-L., Johnson, P. R., & Clark, K. R. (2005) · Journal of Virology · doi:10.1128/jvi.79.23.14793-14803.2005 · Cited by 231
“Also, this integrant possessed 2 base pairs of microhomology with the cellular breakpoint sequence, which was similar to the microhomologies observed in cell culture at sites of recombinant AAV vector integration (29).”
BackgroundSather, B. D., Romano Ibarra, G. S., Sommer, K., Curinga, G., Hale, M., Khan, I. F., Singh, S., Song, Y., Gwiazda, K., Sahni, J., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aac5530 · Cited by 223
“In addition to templating targeted gene addition, rAAV also exhibits nonspecific integration at DNA break sites (37).”
BackgroundRecombinant Adeno-associated Virus Transduction and Integration
Schultz, B. R., & Chamberlain, J. S. (2008) · Molecular Therapy · doi:10.1038/mt.2008.103 · Cited by 215
Sabatino, D. E., Bushman, F. D., Chandler, R. J., Crystal, R. G., Davidson, B. L., Dolmetsch, R., Eggan, K. C., Gao, G., Gil-Farina, I., Kay, M. A., et al. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.06.004 · Cited by 212
(2009) · PubMed
Self-citationSelection of Target Sites for Mobile DNA Integration in the Human Genome
Berry, C., Hannenhalli, S., Leipzig, J., & Bushman, F. D. (2006) · PLoS Computational Biology · doi:10.1371/journal.pcbi.0020157 · Cited by 201
Allele-specific gene editing prevents deafness in a model of dominant progressive hearing loss
György, B., Nist-Lund, C., Pan, B., Asai, Y., Karavitaki, K. D., Kleinstiver, B. P., Garcia, S. P., Zaborowski, M. P., Solanes, P., Spataro, S., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0500-9 · Cited by 196
Transient Gene Expression by Nonintegrating Lentiviral Vectors
Nightingale, S. J., Hollis, R. P., Pepper, K. A., Petersen, D., Yu, X.-J., Yang, C., Bahner, I., & Kohn, D. B. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.01.008 · Cited by 192
Large‐scale molecular characterization of adeno‐associated virus vector integration in mouse liver
Nakai, H., Wu, X., Fuess, S., Storm, T. A., Munroe, D., Montini, E., Burgess, S. M., Grompe, M., & Kay, M. A. (2005) · Journal of Virology · doi:10.1128/jvi.79.6.3606-3614.2005 · Cited by 190
“have demonstrated that rAAV vectors integrate at chromosomal DNA breaks (19).”
BackgroundGenomes in Conflict: Maintaining Genome Integrity During Virus Infection
Weitzman, M. D., Lilley, C. E., & Chaurushiya, M. S. (2010) · Annual Review of Microbiology · doi:10.1146/annurev.micro.112408.134016 · Cited by 186
Gil-Farina, I., Fronza, R., Kaeppel, C., Lopez-Franco, E., Ferreira, V., D'Avola, D., Benito, A., Prieto, J., Petry, H., Gonzalez-Aseguinolaza, G., et al. (2016) · Molecular Therapy · doi:10.1038/mt.2016.52 · Cited by 179
Large-Scale Analysis of Adeno-Associated Virus Vector Integration Sites in Normal Human Cells
Miller, D. G., Trobridge, G. D., Petek, L. M., Jacobs, M. A., Kaul, R., & Russell, D. W. (2005) · Journal of Virology · doi:10.1128/jvi.79.17.11434-11442.2005 · Cited by 171
Self-citationEngineered Viruses as Genome Editing Devices
Chen, X., & Gonçalves, M. A. F. V. (2016) · Molecular Therapy · doi:10.1038/mt.2015.164 · Cited by 151
Analysis of Tumors Arising in Male B6C3F1 Mice with and without AAV Vector Delivery to Liver
Bell, P., Moscioni, A. D., McCarter, R. J., Wu, D., Gao, G., Hoang, A., Sanmiguel, J. C., Sun, X., Wivel, N. A., Raper, S. E., et al. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.03.008 · Cited by 149
Parvoviral Host Range and Cell Entry Mechanisms
Cotmore, S. F., & Tattersall, P. J. (2007) · Advances in virus research · doi:10.1016/s0065-3527(07)70005-2 · Cited by 173
Host Cell DNA Repair Pathways in Adeno-Associated Viral Genome Processing
Choi, V. W., McCarty, D. M., & Samulski, R. J. (2006) · Journal of Virology · doi:10.1128/jvi.00841-06 · Cited by 144
Mátrai, J., Cantore, A., Bartholomae, C. C., Annoni, A., Wang, W., Acosta-Sanchez, A., Samara-Kuko, E., De Waele, L., Ma, L., Genovese, P., et al. (2011) · Hepatology · doi:10.1002/hep.24230 · Cited by 139
“These events may be mediated by nonhomologous end joining of linear episomes to sites of chromosomal breakage.(25) Although we cannot rule out a contribution to the observed sustained FIX expression by these integrated IDLVs, the significant decline of FIX expression with the induction of hepatocyte proliferation afte…”
BackgroundAdenoviral vector DNA for accurate genome editing with engineered nucleases
Holkers, M., Maggio, I., Henriques, S. F. D., Janssen, J. M., Cathomen, T., & Gonçalves, M. A. F. V. (2014) · Nature Methods · doi:10.1038/nmeth.3075 · Cited by 138
No Evidence for Tumorigenesis of AAV Vectors in a Large-Scale Study in Mice
Bell, P., Wang, L., Lebherz, C., Flieder, D. B., Bove, M. S., Wu, D., Gao, G. P., Wilson, J. M., & Wivel, N. A. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.03.020 · Cited by 135
Ferrari, S., Jacob, A., Cesana, D., Laugel, M., Beretta, S., Varesi, A., Unali, G., Conti, A., Canarutto, D., Albano, L., et al. (2022) · Cell stem cell · doi:10.1016/j.stem.2022.09.001 · Cited by 133
The Mre11/Rad50/Nbs1 complex limits adeno-associated virus transduction and replication
Schwartz, R. A., Palacios, J. A., Cassell, G. D., Adam, S., Giacca, M., & Weitzman, M. D. (2007) · Journal of Virology · doi:10.1128/jvi.01523-07 · Cited by 130
Wang, J., DeClercq, J. J., Hayward, S. B., Li, P. W.-L., Shivak, D. A., Gregory, P. D., Lee, G., & Holmes, M. C. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1121 · Cited by 128
“In addition to engaging the homology-directed repair pathways to achieve precise on-target genome editing, AAV genomes can also become inserted at the site of a DSB through NHEJ-mediated end capture events (45–47).”
Precise hit: adeno-associated virus in gene targeting
Vasileva, A., & Jessberger, R. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1266 · Cited by 157
Numt-Mediated Double-Strand Break Repair Mitigates Deletions during Primate Genome Evolution
Hazkani‐Covo, E., & Covo, S. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000237 · Cited by 141
Bak, R. O., Dever, D. P., Reinisch, A., Cruz Hernandez, D., Majeti, R., & Porteus, M. H. (2017) · eLife · doi:10.7554/elife.27873 · Cited by 122
“Although the versatility of the CRISPR/Cas9 system allows for simultaneous manipulation at multiple genetic loci in a single cell, multiplexing of NHEJ-based gene editing has mainly been performed in immortalized human cancer cell lines and mouse cells (Hultquist et al., 2016; Cong et al., 2013; Heckl et al., 2014; Pl…”
MethodInfluentialClinical applications of retinal gene therapy
Lipinski, D. M., Thake, M., & MacLaren, R. E. (2012) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2012.09.001 · Cited by 132
Genome Engineering Using Adeno-associated Virus: Basic and Clinical Research Applications
Gaj, T., Epstein, B. E., & Schaffer, D. V. (2016) · Molecular Therapy · doi:10.1038/mt.2015.151 · Cited by 119
Inactivating intracellular antiviral responses during adenovirus infection
Weitzman, M. D., & Ornelles, D. A. (2005) · Oncogene · doi:10.1038/sj.onc.1209063 · Cited by 149
Genome Editing: A New Approach to Human Therapeutics
Porteus, M. (2016) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010814-124454 · Cited by 114
Haridhasapavalan, K. K., Borgohain, M. P., Dey, C., Saha, B., Narayan, G., Kumar, S., & Thummer, R. P. (2019) · Gene · doi:10.1016/j.gene.2018.11.069 · Cited by 115
Grimm, D., Pandey, K., Nakai, H., Storm, T. A., & Kay, M. A. (2006) · Journal of Virology · doi:10.1128/jvi.80.1.426-439.2006 · Cited by 118
Nowrouzi, A., Penaud-Budloo, M., Kaeppel, C., Appelt, U., Le Guiner, C., Moullier, P., Kalle, C. V., Snyder, R. O., & Schmidt, M. (2012) · Molecular Therapy · doi:10.1038/mt.2012.47 · Cited by 111
An evolved AAV variant enables efficient genetic engineering of murine T cells
Nyberg, W. A., Ark, J., To, A., Clouden, S., Reeder, G. C., Muldoon, J. J., Chung, J.-Y., Xie, W. H., Allain, V., Steinhart, Z., et al. (2023) · Cell · doi:10.1016/j.cell.2022.12.022 · Cited by 118
Targeted Genome Modifications Using Integrase-deficient Lentiviral Vectors
Cornu, T. I., & Cathomen, T. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300345 · Cited by 105
Kim, S., Kim, N., Dong, B., Boren, D., Lee, S. A., Das Gupta, J., Gaughan, C., Klein, E. A., Lee, C., Silverman, R. H., et al. (2008) · Journal of Virology · doi:10.1128/jvi.01299-08 · Cited by 105
Widespread Endogenization of Densoviruses and Parvoviruses in Animal and Human Genomes
Liu, H., Fù, Y., Xiè, J., Chéng, J., Ghabrial, S. A., Li, G., Peng, Y., Yi, X., & Jiāng, D. (2011) · Journal of Virology · doi:10.1128/jvi.00828-11 · Cited by 113
Buck, T., & Wijnholds, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124197 · Cited by 92
“Integration events can be increased by increasing dsDNA breaks in vitro by adding intron-encoded endonuclease I-SceI, etoposide, or γ-irradiation [244].”
BackgroundZinc-Finger Nuclease Based Genome Surgery: Its All About Specificity
Handel, E.-M., & Cathomen, T. (2011) · Current Gene Therapy · doi:10.2174/156652311794520120 · Cited by 101
miRNA cassettes in viral vectors: Problems and solutions
Liu, Y. P., & Berkhout, B. (2011) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2011.05.014 · Cited by 109
Making designer mutants in model organisms
Peng, Y., Clark, K. J., Campbell, J. M., Panetta, M. R., Guo, Y., & Ekker, S. C. (2014) · Development · doi:10.1242/dev.102186 · Cited by 112
Rosas, L. E., Grieves, J. L., Zaraspe, K., La Perle, K. M., Fu, H., & McCarty, D. M. (2012) · Molecular Therapy · doi:10.1038/mt.2012.197 · Cited by 96
Adeno-associated Virus as a Mammalian DNA Vector
Salganik, M., Hirsch, M. L., & Samulski, R. J. (2015) · Microbiology Spectrum · doi:10.1128/microbiolspec.mdna3-0052-2014 · Cited by 87
Wang, L., Yang, Y., Breton, C. A., White, J., Zhang, J., Che, Y., Saveliev, A., McMenamin, D., He, Z., Latshaw, C., et al. (2019) · Blood · doi:10.1182/blood.2019000790 · Cited by 93
Improving miRNA Delivery by Optimizing miRNA Expression Cassettes in Diverse Virus Vectors
Herrera-Carrillo, E., Liu, Y. P., & Berkhout, B. (2017) · Human Gene Therapy Methods · doi:10.1089/hgtb.2017.036 · Cited by 86
Irion, S., Nostro, M. C., Kattman, S. J., & Keller, G. M. (2008) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2008.73.065 · Cited by 83
Targeted nonviral delivery of genome editors in vivo
Tsuchida, C. A., Wasko, K. M., Hamilton, J. R., & Doudna, J. A. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2307796121 · Cited by 90
Episomal Vectors for Gene Therapy
Ehrhardt, A., Haase, R., Schepers, A., Deutsch, M. J., Lipps, H. J., & Baiker, A. E. (2008) · Current Gene Therapy · doi:10.2174/156652308784746440 · Cited by 91
Gene therapy for liver diseases — progress and challenges
Zabaleta, N., Unzu, C., Weber, N. D., & González‐Aseguinolaza, G. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-022-00729-0 · Cited by 80
Adeno-associated Virus: A Key to the Human Genome?
Henckaerts, E., & Linden, R. M. (2010) · Future Virology · doi:10.2217/fvl.10.48 · Cited by 71
“For example, from the AAV vector field, we have learned that recombinant viral genomes have the propensity to attach and, thus, integrate into preformed double-strand breaks [139].”
BackgroundAdeno-associated Vector Toxicity—To Be or Not to Be?
Büning, H., & Schmidt, M. (2015) · Molecular Therapy · doi:10.1038/mt.2015.182 · Cited by 71
Ronen, K., Negre, O., Roth, S., Colomb, C., Malani, N., Denaro, M., Brady, T., Fusil, F., Gillet-Legrand, B., Hehir, K., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2011.20 · Cited by 71
Gene therapy for glycogen storage diseases
Kishnani, P. S., Sun, B., & Koeberl, D. D. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz133 · Cited by 83
Towards a new era in medicine: therapeutic genome editing
Porteus, M. H. (2015) · Genome Biology · doi:10.1186/s13059-015-0859-y · Cited by 69
“For example, recombinant adeno-associated virus (AAV) has a packaging limit of 4.7 kilobases which is too small to package a pair of TALENs or the Cas9 cDNA of S. pyogenes, but not of Staphylococcus aureus [70]. not been determined.”
MethodInfluentialLi, X., Ewis, H. E., Hice, R. H., Malani, N., Parker, N., Zhou, L., Feschotte, C., Bushman, F. D., Atkinson, P. W., & Craig, N. L. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121543109 · Cited by 81
Wang, L., Yang, Y., Breton, C., Bell, P., Li, M., Zhang, J., Che, Y., Saveliev, A., He, Z., White, J., et al. (2020) · Science Advances · doi:10.1126/sciadv.aax5701 · Cited by 67
Evolving AAV-delivered therapeutics towards ultimate cures
He, X., Urip, B. A., Zhang, Z., Ngan, C. C., & Feng, B. (2021) · Journal of Molecular Medicine · doi:10.1007/s00109-020-02034-2 · Cited by 72
Kiourtis, C., Wilczynska, A., Nixon, C., Clark, W. A., May, S., & Bird, T. G. (2021) · Biology Open · doi:10.1242/bio.058678 · Cited by 74
Viral Vector–mediated and Cell-based Therapies for Treatment of Cystic Fibrosis
Flotte, T. R., Ng, P., Dylla, D. E., McCray, P. B., Wang, G., Kolls, J. K., & Hu, J. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300002 · Cited by 72
Händel, E.-M., Gellhaus, K., Khan, K., Bednarski, C., Cornu, T. I., Müller-Lerch, F., Kotin, R. M., Heilbronn, R., & Cathomen, T. (2012) · Human Gene Therapy · doi:10.1089/hum.2011.140 · Cited by 66
Ethical and regulatory aspects of genome editing
Kohn, D. B., Porteus, M. H., & Scharenberg, A. M. (2016) · Blood · doi:10.1182/blood-2016-01-678136 · Cited by 76
CRISPR nuclease off-target activity and mitigation strategies
Wienert, B., & Cromer, M. K. (2022) · Frontiers in Genome Editing · doi:10.3389/fgeed.2022.1050507 · Cited by 77
Homologous recombination is required for AAV-mediated gene targeting
Vasileva, A. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl455 · Cited by 61
Design and potential of non-integrating lentiviral vectors
Shaw, A., & Cornetta, K. (2014) · Biomedicines · doi:10.3390/biomedicines2010014 · Cited by 60
“A significant number of these illegitimate integrations are occurring at sites of chromosomal breakage and are mediated by non-homologous end-joining mechanisms [90,92].”
BackgroundChamorro, C., Mencía, Á., Almarza, D., Duarte, B., Büning, H., Sallach, J., Haußer, I., Río, M. D., Larcher, F., & Murillas, R. (2016) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2016.19 · Cited by 66
High, K. A., & Aubourg, P. (2012) · Methods in Molecular Biology · doi:10.1007/978-1-61779-370-7_18 · Cited by 60
Wang, J., Zhang, C., & Feng, B. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15039 · Cited by 63
Ohbayashi, F., Balamotis, M. A., Kishimoto, A., Aizawa, E., Diaz, A., Hasty, P., Graham, F. L., Caskey, C. T., & Mitani, K. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506598102 · Cited by 67
Wang, Q., Zhong, X., Li, Q., Su, J., Liu, Y., Mo, L., Deng, H., & Yang, Y. (2020) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2020.06.025 · Cited by 61
The Role of Recombinant AAV in Precise Genome Editing
Bijlani, S., Pang, K. M., Sivanandam, V., Singh, A., & Chatterjee, S. (2022) · Frontiers in Genome Editing · doi:10.3389/fgeed.2021.799722 · Cited by 68
Breton, C., Clark, P. M., Wang, L., Greig, J. A., & Wilson, J. M. (2020) · BMC Genomics · doi:10.1186/s12864-020-6655-4 · Cited by 57
Inagaki, K., Piao, C., Kotchey, N. M., Wu, X., & Nakai, H. (2008) · Journal of Virology · doi:10.1128/jvi.01001-08 · Cited by 61
Cytoplasmic Organelle DNA Preferentially Inserts into Open Chromatin
Wang, D., & Timmis, J. N. (2013) · Genome Biology and Evolution · doi:10.1093/gbe/evt070 · Cited by 59
Inagaki, K., Lewis, S. M., Wu, X., Ma, C., Munroe, D. J., Fuess, S., Storm, T. A., Kay, M. A., & Nakai, H. (2007) · Journal of Virology · doi:10.1128/jvi.00963-07 · Cited by 54
Frequent Endonuclease Cleavage at Off-target Locations In Vivo
Petek, L. M., Russell, D. W., & Miller, D. G. (2010) · Molecular Therapy · doi:10.1038/mt.2010.35 · Cited by 53
Self-citationAAV Vectors, Insertional Mutagenesis, and Cancer
Russell, D. W. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300299 · Cited by 53
Self-citationTargeted long-read sequencing captures CRISPR editing and AAV integration outcomes in brain
Simpson, B. P., Yrigollen, C. M., Izda, A., & Davidson, B. L. (2023) · Molecular Therapy · doi:10.1016/j.ymthe.2023.01.004 · Cited by 56
Non-Retroviral Fossils in Vertebrate Genomes
Horie, M., & Tomonaga, K. (2011) · Viruses · doi:10.3390/v3101836 · Cited by 56
Radecke, F., Peter, I., Radecke, S. M., Gellhaus, K., Schwarz, K., & Cathomen, T. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.06.008 · Cited by 54
Cunningham, S. C., Siew, S., Hallwirth, C. V., Bolitho, C., Sasaki, N., Garg, G., Michael, I. P., Hetherington, N. A., Carpenter, K. H., de Alencastro, G., et al. (2015) · Hepatology · doi:10.1002/hep.27842 · Cited by 49
Nicolson, S. C., Li, C., Hirsch, M. L., Setola, V., & Samulski, R. J. (2016) · Journal of Virology · doi:10.1128/jvi.02953-15 · Cited by 48
“Indeed, a previous study has shown that integration of rAAV DNA in vitro increased upon treatment with etoposide (38, 98).”
BackgroundBec, C. L., & Douar, A. M. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302724 · Cited by 54
Metadata
- Authors
- Miller, D. G., Petek, L. M., & Russell, D. W.
- Affiliations
- University of Washington (US)
- Corresponding author
- Russell, David W
- ORCID
- Miller, Daniel G
- Venue
- Nature Genetics
- Published
- 2004-06-20
- Volume
- 36
- Issue
- 7
- Pages
- 767-773
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2050289194
- Cited by
- 266
- References
- 30
- Citations by year
- 2026: 12 · 2025: 11 · 2024: 16 · 2023: 21 · 2022: 12 · 2021: 11 · 2020: 22 · 2019: 11 · 2018: 6 · 2017: 4 · 2016: 11 · 2015: 18 · 2014: 9 · 2013: 7 · 2012: 11
- FWCI
- 7.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (K08DK062100)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Keywords
- adeno-associated virus vectors, viral integration, chromosome breakage, DNA double-strand breaks, I-SceI endonuclease, microhomology, etoposide, gamma irradiation, provirus, mutation rate, gene therapy vectors
- MeSH terms
- Dependovirus, Base Sequence, DNA, Genetic Vectors, Humans, Molecular Sequence Data, Plasmids, Chromosome Fragile Sites, Cell Line, Tumor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.